A genomic appraisal of invasive Salmonella Typhimurium and associated antibiotic resistance in sub-Saharan Africa.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
23 10 2023
Historique:
received: 10 06 2022
accepted: 23 08 2023
medline: 27 10 2023
pubmed: 24 10 2023
entrez: 23 10 2023
Statut: epublish

Résumé

Invasive non-typhoidal Salmonella (iNTS) disease manifesting as bloodstream infection with high mortality is responsible for a huge public health burden in sub-Saharan Africa. Salmonella enterica serovar Typhimurium (S. Typhimurium) is the main cause of iNTS disease in Africa. By analysing whole genome sequence data from 1303 S. Typhimurium isolates originating from 19 African countries and isolated between 1979 and 2017, here we show a thorough scaled appraisal of the population structure of iNTS disease caused by S. Typhimurium across many of Africa's most impacted countries. At least six invasive S. Typhimurium clades have already emerged, with ST313 lineage 2 or ST313-L2 driving the current pandemic. ST313-L2 likely emerged in the Democratic Republic of Congo around 1980 and further spread in the mid 1990s. We observed plasmid-borne as well as chromosomally encoded fluoroquinolone resistance underlying emergences of extensive-drug and pan-drug resistance. Our work provides an overview of the evolution of invasive S. Typhimurium disease, and can be exploited to target control measures.

Identifiants

pubmed: 37872141
doi: 10.1038/s41467-023-41152-6
pii: 10.1038/s41467-023-41152-6
pmc: PMC10593746
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6392

Informations de copyright

© 2023. Springer Nature Limited.

Références

PLoS Negl Trop Dis. 2020 Apr 2;14(4):e0008121
pubmed: 32240161
Microorganisms. 2020 Jul 08;8(7):
pubmed: 32650601
Lancet Infect Dis. 2021 Sep;21(9):1293-1302
pubmed: 34280357
BMJ Glob Health. 2021 Aug;6(8):
pubmed: 34341020
Microb Genom. 2017 Sep 4;3(10):e000131
pubmed: 29177089
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
Bioinformatics. 2015 Oct 15;31(20):3350-2
pubmed: 26099265
Bioinformatics. 2006 Jul 1;22(13):1658-9
pubmed: 16731699
Clin Infect Dis. 2015 Nov 1;61 Suppl 4:S346-53
pubmed: 26449951
Mol Microbiol. 2015 Feb;95(4):678-91
pubmed: 25442048
Antimicrob Agents Chemother. 2013 Jul;57(7):3348-57
pubmed: 23650175
mBio. 2022 Aug 30;13(4):e0037422
pubmed: 35862803
Eur J Epidemiol. 1986 Jun;2(2):99-103
pubmed: 3533612
J Bacteriol. 2000 Mar;182(6):1558-63
pubmed: 10692360
Nucleic Acids Res. 2016 Jul 8;44(W1):W242-5
pubmed: 27095192
PLoS One. 2012;7(7):e42085
pubmed: 22848711
Lancet. 1987 Jun 27;1(8548):1458-61
pubmed: 2885453
EcoSal Plus. 2019 Jan;8(2):
pubmed: 30657108
Syst Biol. 2018 Sep 1;67(5):901-904
pubmed: 29718447
Genome Med. 2014 Nov 20;6(11):90
pubmed: 25422674
Genome Res. 2009 Dec;19(12):2279-87
pubmed: 19901036
Pediatrie. 1991;46(10):691-6
pubmed: 1662357
Microb Genom. 2016 Aug 25;2(8):e000083
pubmed: 28348874
Mol Microbiol. 2003 Feb;47(3):793-805
pubmed: 12535077
Clin Infect Dis. 2015 Nov 1;61 Suppl 4:S317-24
pubmed: 26449947
PLoS Negl Trop Dis. 2015 Mar 24;9(3):e0003611
pubmed: 25803844
PLoS Negl Trop Dis. 2019 Oct 14;13(10):e0007782
pubmed: 31609964
Cell Mol Gastroenterol Hepatol. 2019;7(2):457-473
pubmed: 30765332
Mol Biol Evol. 2013 Feb;30(2):239-43
pubmed: 23090976
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
Pediatr Infect Dis J. 2010 Jun;29(6):504-10
pubmed: 20104200
BMC Bioinformatics. 2008 Dec 16;9:539
pubmed: 19087322
Bioinformatics. 2016 Dec 1;32(23):3566-3574
pubmed: 27503221
Antimicrob Agents Chemother. 2015;59(6):3133-9
pubmed: 25779570
PLoS Negl Trop Dis. 2020 Aug 3;14(8):e0008440
pubmed: 32745137
Microb Genom. 2022 Feb;8(2):
pubmed: 35195512
Microb Genom. 2016 Apr 29;2(4):e000056
pubmed: 28348851
PLoS Genet. 2020 Jun 8;16(6):e1008850
pubmed: 32511244
Mol Microbiol. 1992 Sep;6(18):2661-71
pubmed: 1360139
Science. 2017 Nov 10;358(6364):785-789
pubmed: 29123067
Nat Genet. 2012 Nov;44(11):1215-21
pubmed: 23023330
PLoS Negl Trop Dis. 2017 Jan 5;11(1):e0005118
pubmed: 28056035
Lancet Glob Health. 2017 Mar;5(3):e310-e323
pubmed: 28193398
Lancet. 2012 Jun 30;379(9835):2489-2499
pubmed: 22587967
Mol Biol Evol. 2012 Aug;29(8):1969-73
pubmed: 22367748
Emerg Infect Dis. 2014 Nov;20(11):1957-9
pubmed: 25340988
PLoS Comput Biol. 2017 Jun 8;13(6):e1005595
pubmed: 28594827
Nat Microbiol. 2021 Mar;6(3):327-338
pubmed: 33349664
J Infect. 2021 Nov;83(5):523-532
pubmed: 34260964
PLoS Negl Trop Dis. 2013;7(3):e2103
pubmed: 23516651
Nucleic Acids Res. 2019 Jun 20;47(11):5539-5549
pubmed: 31076776
Genome Res. 2008 May;18(5):821-9
pubmed: 18349386
PLoS Pathog. 2021 Mar 19;17(3):e1009451
pubmed: 33739988
Genome Biol. 2014 Mar 03;15(3):R46
pubmed: 24580807
Open Microbiol J. 2012;6:5-13
pubmed: 22371816
BMC Genomics. 2011 Aug 08;12:402
pubmed: 21824423
J Antimicrob Chemother. 1984 Sep;14 Suppl B:153-9
pubmed: 6094435
Genome Med. 2017 Oct 31;9(1):92
pubmed: 29084588
Vaccine. 2016 Jun 3;34(26):2907-2910
pubmed: 27032517
Antimicrob Agents Chemother. 2014 Jul;58(7):3895-903
pubmed: 24777092
Phytopathology. 2013 Apr;103(4):362-72
pubmed: 23506363
Infect Immun. 2018 Jul 23;86(8):
pubmed: 29784861
Genome Res. 2004 Jul;14(7):1394-403
pubmed: 15231754
Emerg Infect Dis. 2014 Apr;20(4):701-4
pubmed: 24655438
BMC Med. 2020 Jul 17;18(1):212
pubmed: 32677939
Nat Genet. 2015 Jun;47(6):632-9
pubmed: 25961941
Bioinformatics. 2006 Nov 1;22(21):2688-90
pubmed: 16928733
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
Lancet Infect Dis. 2019 Dec;19(12):1312-1324
pubmed: 31562022
Microbes Infect. 2001 Mar;3(3):237-47
pubmed: 11358718
Cell Host Microbe. 2018 Feb 14;23(2):266-273.e4
pubmed: 29447698
Nat Commun. 2019 Sep 19;10(1):4280
pubmed: 31537784
Clin Infect Dis. 2015 Nov 1;61 Suppl 4:S363-71
pubmed: 26449953
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Nat Commun. 2016 Oct 05;7:12827
pubmed: 27703135
Vet Microbiol. 2008 Apr 30;128(3-4):364-73
pubmed: 18068913
Science. 2011 Jan 28;331(6016):430-4
pubmed: 21273480
J Biol Chem. 1991 Oct 15;266(29):19450-8
pubmed: 1918057
Mol Biol Evol. 2012 Sep;29(9):2157-67
pubmed: 22403239
Nucleic Acids Res. 2015 Feb 18;43(3):e15
pubmed: 25414349

Auteurs

Sandra Van Puyvelde (S)

Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0AW, UK. sandra.vanpuyvelde@uantwerpen.be.
Parasites and Microbes Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK. sandra.vanpuyvelde@uantwerpen.be.
Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium. sandra.vanpuyvelde@uantwerpen.be.

Tessa de Block (T)

Institute of Tropical Medicine, Antwerp, Belgium.

Sushmita Sridhar (S)

Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0AW, UK.
Parasites and Microbes Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Division of Infectious Disease, Massachusetts General Hospital, Boston, MA, USA.
Department of Medicine, Harvard Medical School, Boston, MA, USA.

Matt Bawn (M)

Quadram Institute Bioscience, Norwich, UK.
Earlham Institute, Norwich, UK.
Faculty of Biological Sciences, University of Leeds, Leeds, UK.

Robert A Kingsley (RA)

Quadram Institute Bioscience, Norwich, UK.
School of Biological Science, University of East Anglia, Norwich, UK.

Brecht Ingelbeen (B)

Institute of Tropical Medicine, Antwerp, Belgium.
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Mathew A Beale (MA)

Parasites and Microbes Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Barbara Barbé (B)

Institute of Tropical Medicine, Antwerp, Belgium.

Hyon Jin Jeon (HJ)

Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0AW, UK.
International Vaccine Institute, 1 Gwanak-ro, Seoul, 08826, Republic of Korea.
Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.

Lisette Mbuyi-Kalonji (L)

Department of Medical Biology, University Teaching Hospital of Kinshasa, Kinshasa, Democratic Republic of the Congo.
National Institute for Biomedical Research, Kinshasa, Democratic Republic of the Congo.

Marie-France Phoba (MF)

Department of Medical Biology, University Teaching Hospital of Kinshasa, Kinshasa, Democratic Republic of the Congo.
National Institute for Biomedical Research, Kinshasa, Democratic Republic of the Congo.

Dadi Falay (D)

Department of Pediatrics, University Hospital of Kisangani, Kisangani, Democratic Republic of the Congo.

Delphine Martiny (D)

Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles-Universitair Laboratorium Brussel (LHUB-ULB), Université Libre de Bruxelles (ULB), 1000, Brussels, Belgium.
Faculty of Medicine and Pharmacy, University of Mons (UMONS), 7000, Mons, Belgium.

Olivier Vandenberg (O)

Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles-Universitair Laboratorium Brussel (LHUB-ULB), Université Libre de Bruxelles (ULB), 1000, Brussels, Belgium.
Division of Infection and Immunity, Faculty of Medical Sciences, University College London, London, UK.

Dissou Affolabi (D)

Centre National Hospitalier Universitaire Hubert Koutoukou Maga, Cotonou, Benin.

Jean Pierre Rutanga (JP)

Institute of Tropical Medicine, Antwerp, Belgium.
College of Science and Technology, University of Rwanda, Kigali, Rwanda.

Pieter-Jan Ceyssens (PJ)

National Reference Center for Salmonella, Unit of Human Bacterial Diseases, Sciensano, J. Wytsmanstraat 14, B-1050, Brussels, Belgium.

Wesley Mattheus (W)

National Reference Center for Salmonella, Unit of Human Bacterial Diseases, Sciensano, J. Wytsmanstraat 14, B-1050, Brussels, Belgium.

Wim L Cuypers (WL)

Institute of Tropical Medicine, Antwerp, Belgium.
Department of Computer Science, University of Antwerp, Antwerp, Belgium.

Marianne A B van der Sande (MAB)

Institute of Tropical Medicine, Antwerp, Belgium.
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Se Eun Park (SE)

International Vaccine Institute, 1 Gwanak-ro, Seoul, 08826, Republic of Korea.
Yonsei University Graduate School of Public Health, Seodaemun-gu, Seoul, 03722, Republic of Korea.

Simon Kariuki (S)

Kenya Medical Research Institute/Centre for Global Health Research, Kisumu, Kenya.

Kephas Otieno (K)

Kenya Medical Research Institute/Centre for Global Health Research, Kisumu, Kenya.

John P A Lusingu (JPA)

National Institute for Medical Research, Tanga, Tanzania.
Center for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen, København, Denmark.

Joyce R Mbwana (JR)

National Institute for Medical Research, Tanga, Tanzania.

Samuel Adjei (S)

University of Health & Allied Sciences, Ho, Volta Region, Ghana.

Anima Sarfo (A)

University of Health & Allied Sciences, Ho, Volta Region, Ghana.

Seth O Agyei (SO)

University of Health & Allied Sciences, Ho, Volta Region, Ghana.

Kwaku P Asante (KP)

Kintampo Health Research Centre, Research and Development Division, Ghana Health Service, Kintampo North Municipality, Ho, Volta Region, Ghana.

Walter Otieno (W)

KEMRI/Walter Reed Project, Kombewa, Kenya.

Lucas Otieno (L)

KEMRI/Walter Reed Project, Kombewa, Kenya.

Marc C Tahita (MC)

Institut de Recherche en Science de la Santé, Direction Régionale du Centre-Ouest/ClinicalResearch Unit of Nanoro, Nanoro, Burkina Faso.

Palpouguini Lompo (P)

Institut de Recherche en Science de la Santé, Direction Régionale du Centre-Ouest/ClinicalResearch Unit of Nanoro, Nanoro, Burkina Faso.

Irving F Hoffman (IF)

University of North Carolina Project, Lilongwe, Malawi.

Tisungane Mvalo (T)

University of North Carolina Project, Lilongwe, Malawi.
Department of Pediatrics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Chisomo Msefula (C)

Malawi Liverpool Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.

Fatimah Hassan-Hanga (F)

Department of Paediatrics, Bayero University, Kano, Nigeria.
Aminu Kano Teaching Hospital, Kano, Nigeria.

Stephen Obaro (S)

University of Nebraska Medical Center, Omaha, NE, USA.
International Foundation Against Infectious Diseases in Nigeria (IFAIN), Abuja, Nigeria.

Grant Mackenzie (G)

Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Fajara, The Gambia.
London School of Hygiene and Tropical Medicine, Keppel St, Bloomsbury, London, WC1E 7HT, UK.
Murdoch Children's Research Institute, Melbourne, VIC, Australia.

Stijn Deborggraeve (S)

Institute of Tropical Medicine, Antwerp, Belgium.

Nicholas Feasey (N)

University of North Carolina Project, Lilongwe, Malawi.
Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.

Florian Marks (F)

Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0AW, UK.
International Vaccine Institute, 1 Gwanak-ro, Seoul, 08826, Republic of Korea.
Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.
Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.

Calman A MacLennan (CA)

The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Enteric and Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation, Seattle, WA, USA.

Nicholas R Thomson (NR)

Parasites and Microbes Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
London School of Hygiene and Tropical Medicine, Keppel St, Bloomsbury, London, WC1E 7HT, UK.

Jan Jacobs (J)

Institute of Tropical Medicine, Antwerp, Belgium.
Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.

Gordon Dougan (G)

Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0AW, UK.

Samuel Kariuki (S)

Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.

Octavie Lunguya (O)

Department of Medical Biology, University Teaching Hospital of Kinshasa, Kinshasa, Democratic Republic of the Congo.
National Institute for Biomedical Research, Kinshasa, Democratic Republic of the Congo.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH